0001562180-21-007666.txt : 20211213
0001562180-21-007666.hdr.sgml : 20211213
20211213203739
ACCESSION NUMBER: 0001562180-21-007666
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211209
FILED AS OF DATE: 20211213
DATE AS OF CHANGE: 20211213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DECICCO CARL
CENTRAL INDEX KEY: 0001828727
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 211489450
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
STREET 2: SUITE 610
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-12-09
false
0001822462
Foghorn Therapeutics Inc.
FHTX
0001828727
DECICCO CARL
500 TECHNOLOGY SQUARE
STE 700
CAMBRIDGE
MA
02139
false
true
false
false
Chief Scientific Officer
Common Stock
2021-12-09
4
M
false
104310.00
3.72
A
362707.00
D
Stock Options (Right to buy)
3.72
2021-12-09
4
M
false
76892.00
0.00
D
2029-02-20
Common Stock
76892.00
186571.00
D
Stock Options (Right to buy)
3.72
2021-12-09
4
M
false
27418.00
0.00
D
2029-02-20
Common Stock
27418.00
34273.00
D
The option vested as to 25% of the underlying shares of common stock on December 10, 2019, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
/s /Allan Reine, M.D., Attorney-in-Fact
2021-12-13